Erdogan, B.R.; Yesilyurt-Dirican, Z.E.; Karaomerlioglu, I.; Muderrisoglu, A.E.; Sevim, K.; Michel, M.C.; Arioglu-Inan, E.
Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes. Int. J. Mol. Sci. 2024, 25, 10617.
https://doi.org/10.3390/ijms251910617
AMA Style
Erdogan BR, Yesilyurt-Dirican ZE, Karaomerlioglu I, Muderrisoglu AE, Sevim K, Michel MC, Arioglu-Inan E.
Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes. International Journal of Molecular Sciences. 2024; 25(19):10617.
https://doi.org/10.3390/ijms251910617
Chicago/Turabian Style
Erdogan, Betul R., Zeynep E. Yesilyurt-Dirican, Irem Karaomerlioglu, Ayhanim Elif Muderrisoglu, Kadir Sevim, Martin C. Michel, and Ebru Arioglu-Inan.
2024. "Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes" International Journal of Molecular Sciences 25, no. 19: 10617.
https://doi.org/10.3390/ijms251910617
APA Style
Erdogan, B. R., Yesilyurt-Dirican, Z. E., Karaomerlioglu, I., Muderrisoglu, A. E., Sevim, K., Michel, M. C., & Arioglu-Inan, E.
(2024). Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes. International Journal of Molecular Sciences, 25(19), 10617.
https://doi.org/10.3390/ijms251910617
